Sun Pharma Advanced Research Company shareholding pattern

SPARC

MiscellaneousMid

143.61

3.37 (2.40%)
Last updated on 18 Aug, 2025 | 15:45 IST
BUYSELL

The current prices are delayed, login to your account for live prices

Sun Pharma Advanced Research Company Shareholding Pattern

  • 2016-17
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2024-25
  • 2025-26
  • 2023-24
Total Promoters
Segment
Percent

Total Promoters

65.67%

Mutual Fund

0.51%

Insurance

0.01%

Foreign Institutional Investors

2.23%

Domestic Institutional Investors

0.1%

Retail

31.48%

Others

0%

Total Promoters
MAR '24
65.67%
JUN '24
65.67%
SEP '24
65.67%
DEC '24
65.67%

Sun Pharma Advanced Research Company FAQs

As of 08-2025, the promoter shareholding in Sun Pharma Advanced Research Company stands at 65.67% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.

The FII and DII shareholding of Sun Pharma Advanced Research Company is 1.48% and 0.01% respectively.

The retail shareholding of the Sun Pharma Advanced Research Company is 31.89%.

Changes in shareholding patterns of Sun Pharma Advanced Research Company can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.

Shareholding patterns of Sun Pharma Advanced Research Company are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.

The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.